The Relationship between Defective Heparin Cofactor Activities and Thrombotic Phenomena in AT III Abnormalities

Antonio Girolami; Anna Rosa Lazzaro; Paolo Simioni

doi:10.1055/s-0038-1642577

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1988; 59(01): 121
DOI: 10.1055/s-0038-1642577

Review Article

Schattauer GmbH Stuttgart

The Relationship between Defective Heparin Cofactor Activities and Thrombotic Phenomena in AT III Abnormalities

Antonio Girolami

University of Padua Medical School, Institute of Medical Semeiotics and II Chair Medicine, Via Ospedale 105, 35100 Padua, Italy

,

Anna Rosa Lazzaro

University of Padua Medical School, Institute of Medical Semeiotics and II Chair Medicine, Via Ospedale 105, 35100 Padua, Italy

,

Paolo Simioni

University of Padua Medical School, Institute of Medical Semeiotics and II Chair Medicine, Via Ospedale 105, 35100 Padua, Italy

› Author Affiliations

Abstract

PDF Download

PDF (120 kb)

References

References
1 Mannucci P.M., Tripodi A.. Laboratory screening of inherited thrombotic syndromes. Thromb Haemostas 1987; 57: 247-51
2 Chasse JF, Esnard F, Guitton J, Mouray H, Perigois F, Fauconneau G, Gauthier F. An abnormal plasma antithrombin with no apparent affinity for heparin. Thromb Res 1984; 50: 297-302
3 Fischer AM, Gazengel C, Dautzenberg MD, Benhammo J, Béguin S, Vergoz D. A new case of abnormal antithrombin III (AT III): biological characteristics and thromboembolic accidents management. Thromb Haemostas 1983; 50: 358 (Abstr)
4 Fischer AM, Cornu P, Sternberg C, Mériane F, Chafa O, Dautzenberg MD, Béguin S, Desnos M. Antithrombin III Alger: a new homozygous AT III variant. Thromb Haemostas 1986; 55: 218-21
5 Girolami A, Pengo V, Patrassi GM, Cappellato G, Vianello C, Cartei L. Antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease. Folia Haematol 1983; 110: 98-111
6 Girolami A, Fabris F, Cappellato G, Sainati L, Boeri G. Antithrombin III Padua: a new congenital abnormality with defective heparin cofactor activities but no thrombotic disease. Blut 1983; 47: 93-103
7 Girolami A, Marafioti F, Rubertelli M, Vicarioto MA, Cappellato G, Mazzuccato M. Antithrombin III Trento: a new congenital AT III abnormality with peculiar crossed immunoelectrophoretic pattern in the absence of heparin. Acta Haematol 1984; 72: 73-82
8 Girolami A. The incidence of thrombotic manifestations in AT III abnormalities. Thromb Haemostas 1987; 57: 123
9 Girolami A. A tentative classification of AT III congenital abnormalities. Folia Haematol (in press)
10 Koide T, Takahashi K, Odami S, Ono T, Sakuragawa N. Isolation and characterization of a hereditary abnormal antithrombin III “antithrombin Tokoama”. Thromb Res 1983; 31: 319-328
11 Boyer C, Wolf M, Vedrenne J, Meyer D, Larrieu MJ. Homozygous variant of Antithrombin III: AT III Fantainebleau. Thromb Haemostas 1986; 56: 18-22
12 Moerloose PA, de Reber G, Vernet Ph, Minazio Ph, Bouvier CA. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity. Thromb Haemostas 1987; 57: 154-7
13 Penner JA, Hassouna H, Hunter MJ, Chockley M. A clinically silent antithrombin III defect in an Ann Arbor family. Thromb Haemostas 1979; 42: 186 (Abstr)
14 Tran TH, Bounameaux H, Bondeli C, Honkanen H, Marbet GA, Duckcrt F. Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis. Thromb Haemostas 1980; 44: 87-91
15 Wolf M, Boyer C, Lavergne JM, Larrieu MJ. A new familial variant of antithrombin III: antithrombin III Paris. Br J Haematol 1982; 51: 285-95